Also from this source


You just read:

Roivant Sciences and Plexcera Therapeutics Announce the Formation of Enzyvant Sciences to Focus on the Treatment of Farber Disease

News provided by

Roivant Sciences Ltd.

12 Jul, 2016, 22:46 ET